Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 5
2003 7
2004 9
2005 23
2006 15
2007 13
2008 10
2009 7
2010 15
2011 5
2012 13
2013 9
2014 15
2015 13
2016 14
2017 11
2018 5
2019 6
2020 1
2021 4
2022 6
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Results by year

Filters applied: . Clear all
Page 1
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial.
Subbiah V, Kreitman RJ, Wainberg ZA, Gazzah A, Lassen U, Stein A, Wen PY, Dietrich S, de Jonge MJA, Blay JY, Italiano A, Yonemori K, Cho DC, de Vos FYFL, Moreau P, Fernandez EE, Schellens JHM, Zielinski CC, Redhu S, Boran A, Passos VQ, Ilankumaran P, Bang YJ. Subbiah V, et al. Among authors: zielinski cc. Nat Med. 2023 May;29(5):1103-1112. doi: 10.1038/s41591-023-02321-8. Epub 2023 Apr 14. Nat Med. 2023. PMID: 37059834 Free PMC article. Clinical Trial.
Triple-negative breast cancer.
Bartsch R, Ziebermayr R, Zielinski CC, Steger GG. Bartsch R, et al. Among authors: zielinski cc. Wien Med Wochenschr. 2010 Apr;160(7-8):174-81. doi: 10.1007/s10354-010-0773-6. Wien Med Wochenschr. 2010. PMID: 20473728 Free article. Review.
How I treat cancer special issue.
Zielinski CC. Zielinski CC. ESMO Open. 2019 May 1;4(Suppl 2):e000514. doi: 10.1136/esmoopen-2019-000514. eCollection 2019. ESMO Open. 2019. PMID: 31231575 Free PMC article. No abstract available.
CSCO joins ESMO Open-Cancer Horizons.
Zielinski CC, Wu YL. Zielinski CC, et al. ESMO Open. 2016 Nov 18;1(5):e000120. doi: 10.1136/esmoopen-2016-000120. eCollection 2016. ESMO Open. 2016. PMID: 27933216 Free PMC article. No abstract available.
Angiogenesis in cancer: Anti-VEGF escape mechanisms.
Prager GW, Poettler M, Unseld M, Zielinski CC. Prager GW, et al. Among authors: zielinski cc. Transl Lung Cancer Res. 2012 Mar;1(1):14-25. doi: 10.3978/j.issn.2218-6751.2011.11.02. Transl Lung Cancer Res. 2012. PMID: 25806151 Free PMC article. Review.
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.
Kornauth C, Pemovska T, Vladimer GI, Bayer G, Bergmann M, Eder S, Eichner R, Erl M, Esterbauer H, Exner R, Felsleitner-Hauer V, Forte M, Gaiger A, Geissler K, Greinix HT, Gstöttner W, Hacker M, Hartmann BL, Hauswirth AW, Heinemann T, Heintel D, Hoda MA, Hopfinger G, Jaeger U, Kazianka L, Kenner L, Kiesewetter B, Krall N, Krajnik G, Kubicek S, Le T, Lubowitzki S, Mayerhoefer ME, Menschel E, Merkel O, Miura K, Müllauer L, Neumeister P, Noesslinger T, Ocko K, Öhler L, Panny M, Pichler A, Porpaczy E, Prager GW, Raderer M, Ristl R, Ruckser R, Salamon J, Schiefer AI, Schmolke AS, Schwarzinger I, Selzer E, Sillaber C, Skrabs C, Sperr WR, Srndic I, Thalhammer R, Valent P, van der Kouwe E, Vanura K, Vogt S, Waldstein C, Wolf D, Zielinski CC, Zojer N, Simonitsch-Klupp I, Superti-Furga G, Snijder B, Staber PB. Kornauth C, et al. Among authors: zielinski cc. Cancer Discov. 2022 Feb;12(2):372-387. doi: 10.1158/2159-8290.CD-21-0538. Epub 2021 Oct 11. Cancer Discov. 2022. PMID: 34635570 Free PMC article.
188 results